CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells - Wikidata - wikimedia - TriplyDB

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

http://www.wikidata.org/entity/Q24681974

about

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing Lymphoma Immunotherapy: Current Status Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.FOXP3 and GARP (LRRC32): the master and its minion Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor.TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma Perspectives on Regulatory T Cell Therapies.Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome.Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma Expression of the immune regulation antigen CD70 in osteosarcoma.Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.CD28 costimulation is essential for human T regulatory expansion and function Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.CD70 as a therapeutic target in human malignancies.Regulatory T cells and treatment of cancer.B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth.The microenvironment in mature B-cell malignancies: a target for new treatment strategies The Roles of Radiotherapy and Immunotherapy for the Treatment of Lymphoma ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.Unravelling the complexity of cancer-immune system interplay.The challenge of the microenvironment in B-cell lymphomas.The four types of Tregs in malignant lymphomas.Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab.Therapeutic targeting of CD70 and CD27.CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.

P2860

Q24598725-97187EF9-CEA1-494E-BFA1-8FAA3FB04DA8 Q26752197-E85CFA36-3909-4CCB-B937-18280B84AADE Q26782902-43F9D819-81B6-45FF-A001-26A19EEFEED1 Q31090571-6220A859-9E9C-4A6C-91F5-E9B90D5F13F1 Q33417191-45596D4A-D540-4DDD-9AA2-A0F7D3F48854 Q33673969-1CA56AD2-402C-4B8A-9E67-8D803FA69649 Q33985141-C959C197-37F2-46B8-A5B1-AF31FF5B39D1 Q34090686-5FC15BD9-68AF-46F9-A85F-CF776B80817F Q34103249-6326777A-DD6E-4366-8182-C86F36D1EA68 Q34263542-4CBE3F91-E3AD-4A9A-BDA6-D09804D2BCEB Q34532146-B3AD3DF8-F4BB-4486-9325-AA6F0835326A Q34649178-915E169B-A1CE-4311-AA21-DE14B5728432 Q34923799-072A2CDE-AC09-4945-8E10-CDA091D8413C Q35154940-CA839D97-7AA0-4564-94D8-AAB5DC547751 Q35194116-B3A69547-B094-44F8-A778-22B368867839 Q35700316-1456D5CB-4BEA-4E25-B805-BF0B4B48F6E6 Q35955354-7E646254-0104-4A11-A14C-535A9D243B4C Q36191426-156AB634-6A63-4B1C-9BEA-B38E140DCBB2 Q36628291-3CDEE3AB-8BFC-4C0D-9CB7-D6AB80F0FF2C Q36916914-D7F8D392-1E58-4AFD-8E71-8898E67EFF89 Q36922528-D6C47253-3ACF-48B2-896C-42218D292806 Q37073655-6E100146-CCAE-417C-B8A2-7BC40002C78C Q37082785-BFA2C409-C717-49E2-9EAE-F2C546DC1DF9 Q37174953-26F3EA4E-5E83-44A7-B7CC-7C7E042C6ED6 Q37348263-8DB1EB08-F26E-4316-8D48-ABD5F42262F4 Q37373035-D36D726D-2F84-4521-832F-4967C0D6B4DD Q37556159-B601E97B-24BB-4C2E-8546-34ECEC197263 Q37563816-96945A6D-8D88-4297-9AD0-0C98830A0E2D Q37640319-34B6497F-6BA5-4026-A954-4580B4BE3839 Q37698951-D1B31CBA-9336-4D55-95D6-739646A7CE72 Q37765590-78EC5A8A-566C-4AC1-89A6-7164B2833BD7 Q37831956-59046DCA-D05A-4F22-AAAF-485A36821CDA Q37966000-8506B530-AB09-48C0-A311-E7A83CC04C0A Q37971736-336A86BA-4F01-4896-8314-E01A60AA3375 Q38344066-EE252527-6807-4832-B152-C54026945080 Q38636284-EFEFA33F-3234-40D6-B488-AD50009CC7F6 Q38749841-06E6F235-C567-4F68-A2D6-161599857BCC Q38850275-B89CDC3E-79A6-4EAD-80E9-0A26FC602E20 Q38889427-5E07D73E-D0A1-4401-8B26-4A7B9EBF1B74 Q39043404-1BF5ADDB-E685-46B0-BC8E-CE9F77A6427F

P2860

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

http://www.wikidata.org/entity/Q24681974

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@ast

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@en

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@nl

type

label

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@ast

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@en

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@nl

prefLabel

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@ast

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@en

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@nl

P1433

Q24681974-7FBA8445-8081-444A-976C-11066DC61796

P1476

Q24681974-4DF383C8-C9B8-4A62-8EAB-D307C5BAAC77

P2093

Q24681974-11DAD6F9-7146-413D-99DD-04D441A006D7

Q24681974-4CB9220C-52D1-4C1C-B87E-DD7BD0605F18

Q24681974-C96D4203-6BF3-4E4A-8D64-B43EB979728D

Q24681974-D9ECCD71-21BE-4C27-81AB-91151197C11A

Q24681974-E0FAE4A0-0730-4B72-AAAC-AB76B0C0A48B

P2860

Q24681974-05635130-43EC-4E20-876E-545883439FDA

Q24681974-0AAAEFE6-38F5-456D-BB33-61C05FD52768

Q24681974-17F7133A-C7F3-48EC-980E-000CAC3D5B95

Q24681974-1F3796E0-3722-4D2C-A746-374C7973CEF8

Q24681974-210861D5-DD81-4B93-89F4-DC80F3B7A85E

Q24681974-2D34FEA3-E0CD-4461-B449-F6974071DE8D

Q24681974-2DA5994A-E512-4207-ACAC-2EDC1AA7BE4A

Q24681974-2FA2B936-5ED2-435B-A03A-291D7FC05F76

Q24681974-37F90BF2-4F15-4640-97C4-0A4BBBC034F0

Q24681974-4AAC7F66-D1A1-4AE4-95B7-DFA7C3C0E10C

P304

Q24681974-58EC0140-33E2-4C20-BAD9-C9F10C5C1672

P31

Q24681974-B74B9243-6815-4840-8DFB-E8017BCF5989

P3181

Q24681974-169C7153-FC27-4343-A49F-FA24E2BE6CBF

P356

Q24681974-A548EB4A-B041-4746-B23F-E4A6CB3EA520

P407

Q24681974-F0294E5D-B87A-4998-AC41-B51C9AB0A97F

P433

Q24681974-6BC408A8-4118-4AA8-9C18-130DA3F6B4EA

P478

Q24681974-DBB9785B-62E0-4261-AD18-4302C39CD4E2

P577

Q24681974-06DD18D9-92B6-45B2-AFD6-0F00D6EE72C3

P5875

Q24681974-7195E893-5C4F-4F15-95B1-3DE7EB53E0BB

P698

Q24681974-E1590313-5878-46B3-8117-9A6570AD7695

P921

Q24681974-3EC6510B-9BA7-42D3-A0D1-6686D2A2ED1D

P932

Q24681974-3C6A5746-21FC-400F-948F-B6CCB0C6CA65

P3181

P356

BLOOD-2007-03-082578

P1433

P1476

CD70+ non-Hodgkin lymphoma B c ...... intratumoral CD4+CD25 T cells

@en

P2093

Anne J Novak

http://www.w3.org/2001/XMLSchema#string

Stephen M Ansell

http://www.w3.org/2001/XMLSchema#string

Steven C Ziesmer

http://www.w3.org/2001/XMLSchema#string

Thomas E Witzig

http://www.w3.org/2001/XMLSchema#string

Zhi-Zhang Yang

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

An essential role for Scurfin in CD4+CD25+ T regulatory cells

Immunosuppressive strategies that are mediated by tumor cells

P304

2537-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4899224

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2007-03-082578

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6223202

http://www.w3.org/2001/XMLSchema#string

P698

17615291

http://www.w3.org/2001/XMLSchema#string

P921

P932

1988926

http://www.w3.org/2001/XMLSchema#string